Gainers
Evaxion Biotech (NASDAQ:EVAX) shares moved upwards by 16.07% to $6.5 during Friday’s after-market session. Trading volume for this security closed at 1.6K, accounting for 2.03% of its average full-day volume over the last 100 days. As per the news, the Q1 earnings report came out yesterday.
Clearside Biomedical (NASDAQ:CLSD) stock moved upwards by 8.4% to $2.58. This security traded at a volume of 3.6K shares come close, making up 1.2% of its average volume over the last 100 days. The company’s market cap stands at $148.5 million.
Salarius Pharmaceuticals (NASDAQ:SLRX) shares rose 3.75% to $1.38. Trading volume for this security closed at 7.4K, accounting for 0.5% of its average full-day volume over the last 100 days. The company’s market cap stands at $61.7 million. As per the news, the Q1 earnings report came out 2 days ago.
• PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter.
• Boyd Gaming (NYSE:BYD) is projected to report quarterly earnings at $1.01 per share on revenue of $570.79 million.
• Zealand Pharma (NASDAQ:ZEAL) is likely to report quarterly loss at $1.01 per share on revenue of $9.89 million.
• American Well (NYSE:AMWL) is likely to report quarterly loss at $0.19 per share on revenue of $58.75 million.
• Crescent Point Energy (NYSE:CPG) is projected to report quarterly earnings at $0.03 per share on revenue of $492.10 million.
• TORM (NASDAQ:TRMD) is expected to report quarterly loss at $0.21 per share on revenue of $130.30 million.
• Dream Finders Homes (NASDAQ:DFH) is likely to report quarterly earnings at $0.19 per share on revenue of $350.23 million.
Shares of Salarius Pharmaceuticals (NASDAQ:SLRX) rose in after-market trading after the company reported Q1 results.
Quarterly Results
Earnings per share .
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Salarius Pharmaceuticals to Report First Quarter 2021 Financial Results
Salarius Pharmaceuticals, Inc.May 5, 2021 GMT
HOUSTON, May 05, 2021 (GLOBE NEWSWIRE) Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, today announced that the Company will host a conference call and live audio webcast on Wednesday, May 12, 2021, at 5:00 p.m. ET, to discuss its corporate and financial results for the first quarter 2021.
Conference Call Information:
(833) 423-0481 (U.S.) Conference ID: 9062629
An audio webcast will be accessible via the Investors Events and Presentations section of the Company’s website http://investors.salariuspharma.com/. An archive of the webcast will remain available for 90 days beginning at approximately 5:30 p.m. ET, on�